Amneal Pharmaceuticals, Inc.
AMRX · Pharmaceutical Preparations
Latest available SEC filing: 4 ·
Latest disclosures
-
Buchi J Kevin: Form 4
Insider disclosure · Filed · Report period 17 Sep 2026
-
Form 4
SEC filing · Filed
-
Form 4
SEC filing · Filed
-
Form 4
SEC filing · Filed
-
Form 4
SEC filing · Filed
-
Form 4
SEC filing · Filed
-
Form 4
SEC filing · Filed
-
Latest financial period: Q2 2026
Financial facts · Filed
Institutional holders by security
Choose a share class to see reported 13F positions and quarterly changes. Different securities have separate holder histories.
- AMRX · 03168L105 - Class A Common Stock, par value $0.01
Company details and SEC sources
CIK 0001723128 · SEC filing index. Filing dates describe disclosures, not live market data.
- Listed symbols
- AMRX on Nasdaq
- SEC industry group
- Pharmaceutical Preparations (Office of Life Sciences)
- Business address
- 400 Crossing Boulevard, 3 Rd Floor, Bridgewater, NJ, 08807
- Fiscal year end
- 31 December
- Former names on EDGAR
- Atlas Holdings, Inc. (to 13 Apr 2018)
At a glance
Names, identifiers, and filing context for this profile.
2 identity fields